Searchable abstracts of presentations at key conferences in endocrinology

ea0016p772 | Thyroid | ECE2008

Usefulness of thyroid echographic pattern description: predictive value at onset and in the evolution of thyroid diseases

Peretianu Dan , Staicu Daniela Cristea , Carsote Mara

Objectives: The study of the real indications for thyroid ultrasound and in which pathological conditions the echography is of real use and not for abuse.Material and methods: In the last 10 years, over 13 000 echographies were performed in 5136 consecutive patients for ‘thyroid disturbances’. In a previous paper we described 7 echographic patterns for thyroid ultrasound (9th ECE). The diagnosis of Hashimoto’s thyroiditis (HT) was consider...

ea0014p504 | (1) | ECE2007

Unusual onset of Graves’ disease – case report

Cristea Cristina , Ciornohuz Adriana , Zbranca Eusebie

Graves’ thyrotoxicosis frequently occurs after delivery through immune rebound mechanism. A 34 years old patient, in postpartum period was referred to rheumatologist for gradually gait impairment. Examination showed only weakness of pelvic girdle muscles which required an extensive differential diagnosis including: neurological diseases and inflammatory/metabolic/toxic myopathies. Routine lab tests were unremarkable except low cholesterol (128 mg/dl) and slightly increase...

ea0026p641 | Clinical case reports | ECE2011

Multiple pituitary deficiencies in a young patient with primary empty sella

Rusu A , Cristea C , Gheorghiu L , Balcan R , Mogos V

Introduction: Usually, the hormonal profile is normal in patients with empty sella. However, when present, hormonal deficiency most commonly consist in growth disturbance in children and mild hyperprolactinaemia in adults. Hypopititarism with signs of symptomatic dysfunction occurs in <10% of patient with primary empty sella.Case report: A 27-years-old man presented to our department in 2008 with impuberism, micropenis, hypoplasic scrotum, inguinal g...

ea0016p545 | Obesity | ECE2008

The volume of left hepatic lobe as metabolic marker, correlates with weight and not with height, both in obese or non-obese women and men

Peretianu Dan , Carsote Mara , Staicu Daniela Cristea , Poiana Catalina

Introduction: Left hepatic lobe volume (LHLV) has been associated with hyperinsulinemia and insulin resistance in obese women.Aim: To study the correlation between LHLV and body weight, regardless the weight and gender of the patient.Subjects and methods: The left hepatic lobe was evaluated with an echographic probe of 3.5 MHz. The LHLV (cm3) was calculated with the formula: antero-posterior diameter (length)×longit...

ea0014p591 | (1) | ECE2007

Self-concept in patients with PCOS

Gotca Ioan , Cristea Cristina , Leustean Letitia , Ioana Draghici , Zbranca Eusebie

Polycystic ovary syndrome (PCOS) is a major source of psychological morbidity and can negatively affect quality of life. The aim of the study was to identify characteristics of self-concept in female patients diagnosed with PCOS (n=22, mean age 26+/− 11 years) and comparative analysis with a control group (n=22).Methods: Psychology questionnaire, selection tests based on geometrical figures/ words and also graph logical analysis were ...

ea0032p607 | Female reproduction | ECE2013

Main determinants of serum uric acid concentrations in polycystic ovary syndrome patients

Leustean Letitia , Preda Cristina , Ungureanu Maria Christina , Cristea Cristina , Mogos Voichita , Ungureanu Didona , Vulpoi Carmen

Introduction: Uric acid may increase cardiovascular risk, exerting proinflammatory, pro-oxidant and proliferative actions at the endothelial cell level. Classic and non-classic cardiovascular risk markers cluster in women with polycystic ovary syndrome (PCOS), uric acid being proposed as one of them. The studies available at present regarding serum uric acid levels in PCOS patients are scarce and controversial. The aim of the study was to examine the relationship between uric ...

ea0029p966 | Female Reproduction | ICEECE2012

Clinical, hormonal and metabolic profile in overweight and obese women with polycystic ovary syndrome

Leustean L. , Preda C. , Fica S. , Ungureanu M. , Cristea C. , Ungureanu D. , Mogos V. , Vulpoi C.

Polycystic ovary syndrome (PCOS) is a heterogeneous condition affecting 5–10% of reproductive -age female population.The aim of this study was to determine the clinical features, metabolic and hormonal profile in obese and overweight women with PCOS.Patients and method: A total of 102 women (age 31.28±6.05 and BMI 33.02±5.93) with PCOS and 110 (age 32.35±4.96 and BMI 33.05±5.87) matched controls were invest...

ea0014p180 | (1) | ECE2007

Lower catch-up growth under rGH therapy at pre-pubertal pituitary dwarves diagnosed at an older age

Branisteanu Dumitru , Galesanu Corina , Cristea Cristina , Zbranca Eusebie , Vulpoi Carmen , Preda Cristina , Mogos Voichita

Growth hormone deficiency leads to profoundly decreased growth velocity and, when untreated, to pituitary dwarfism. We evaluated growth evolution for one to four years under rGH therapy (0.07 IU/kg/day, subcutaneously) at seventeen idiopathic pituitary dwarves with isolated GH deficiency, 13 boys and 4 girls, with a wide span of age at therapy onset (between 4 and 24 years old). Diagnosis was set subsequent to at least two negative GH stimulation tests. All patients were pre-p...

ea0014p470 | (1) | ECE2007

Thyrotoxic hypokalemic periodic paralysis in two Caucasian females

Preda Cristina , Leustean Letitia , Vulpoi Carmen , Cristea Cristina , Ungureanu Christina , Zbranca Eusebie

Hypokalemic periodic paralysis is an uncommon complication of thyrotoxicosis especially in Caucasian women. It is most frequent in east asian and Japanese males and is characterized by recurrent episodes of motor weekness of variable intensity associated with hyperthyroidism. It is usually associated with low plasma potassium levels and is often precipitated by physical activity. This condition is a self limiting disorder that is cured by the treatment of the underlying hypert...

ea0011p209 | Clinical practise and governance | ECE2006

Does HT still have a place? The impact on menopausal-related symptoms

Cristea C , Vulpoi C , Ungureanu MC , Leustean L , Concita C , Mogos V , Zbranca E

Hormonal treatment (HT) represents the only complete therapy of the consequences of the postmenopausal estrogenic deficiency. Quality of life in postmenopausal women is often compromised. We evaluated the quality of life (appreciated with IQL questionnaire) in 80 postmenopausal women – 40 with intact uterus, treated with natural estrogens associated with progestin, and 40 non-treated women. Group selection (treated/not treated) was made function of the inform consent of t...